← Ticker index
GMAB
Ticker
GMAB
Congressional Trades
8
by 1 members
Ticker disclosure brief
Congressional disclosure records for GMAB
A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.
Latest receipt
Josh Gottheimer
BUY · 2025-01-16
Largest range
$1K – $15K
Josh Gottheimer
Longest observed gap
29d
Josh Gottheimer
Highest 30d vs SPY
21.1%
Josh Gottheimer
Purchase rows
4
50%
Sale rows
4
50%
Disclosed midpoint
$64K
range estimate
Unique Traders
1
members
Disclosure timing method
Observed filing gaps are not notice-date findings
The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.
Party Breakdown
Democrats8 · 100%
Republicans0 · 0%
Lobbying filings
all →- 2026-07-15$60KGENMAB US INC.
- 2026-04-20$60KGENMABPrescription Drug Pricing. Implementation of Inflation Reduction Act of 2022. General Medicare/Medicaid Issues. 340B Issues.
- 2026-04-15$60KGENMAB US INC.
- 2026-01-20$60KGENMABGeneral Medicare/Medicaid Issues. 340B Issues. Prescription Drug Pricing. Implementation of Inflation Reduction Act of 2022.
- 2026-01-14$60KGENMAB US INC.
- 2025-10-15$60KGENMAB US INC.Guidance on legislation and regulations regarding the creation and development of differentiated antibody therapeutics.
- 2025-10-12$60KGENMABPrescription Drug Pricing. Implementation of Inflation Reduction Act of 2022. General Medicare/Medicaid Issues. 340B Issues.
- 2025-07-19$60KGENMABPrescription Drug Pricing. Implementation of Inflation Reduction Act of 2022. General Medicare/Medicaid Issues. 340B Issues.
- 2025-07-15$60KGENMAB US INC.Guidance on legislation and regulations regarding the creation and development of differentiated antibody therapeutics.
- 2025-04-21$60KGENMABPrescription Drug Pricing. Implementation of Inflation Reduction Act of 2022. General Medicare/Medicaid Issues. Safe STEP Act. 340B Issues.
Loading trade analytics…
All Disclosed Trades
Page 1 · 8 of 8 shown| Date | Member | Action | Amount | Observed Gap | Receipt |
|---|---|---|---|---|---|
| 2025-01-16 | DJosh Gottheimer | BUY | $1K – $15K | 25d | receipt → |
| 2025-01-16 | DJosh Gottheimer | BUY | $1K – $15K | 25d | receipt → |
| 2024-12-16 | DJosh Gottheimer | SELL | $1K – $15K | 29d | receipt → |
| 2024-12-16 | DJosh Gottheimer | SELL | $1K – $15K | 29d | receipt → |
| 2024-07-19 | DJosh Gottheimer | BUY | $1K – $15K | 27d | receipt → |
| 2024-07-19 | DJosh Gottheimer | BUY | $1K – $15K | 27d | receipt → |
| 2024-06-18 | DJosh Gottheimer | SELL | $1K – $15K | 21d | receipt → |
| 2024-06-18 | DJosh Gottheimer | SELL | $1K – $15K | 21d | receipt → |
“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.